| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |